Journal
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 74B, Issue 6, Pages 331-340Publisher
WILEY
DOI: 10.1002/cyto.b.20430
Keywords
standardization; flow cytometry; leukemia; residual disease
Categories
Funding
- Austrian National Bank [10962]
- Wilhelm Sander Stiftung [2004.072.1]
- Ministero dell'Universita a Ricerca Scientifica a Tecnologica, Associazione Italiana per la Ricerca sul Cancro
Ask authors/readers for more resources
Background: Single-laboratory experience showed that flow cytometric (FCM) assessment of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) is feasible in most patients and gives independent prognostic information. It is, however, not known whether FCM analysis can reliably be standardized for multicentric application. Methods: An extensive standardization program was installed in four collaborating laboratories, which study FCM-MRD in children treated with the AIEOP-BFM-ALL 2000 protocol. This included methodological alignment, continuous quality monitoring, as well as personnel education by exchange and performance feed-back. Results: Blinded inter-laboratory tests of list-mode data interpretation concordance (n = 202 blood and bone marrow samples from follow-up during induction of 31 randomly selected patients of a total series of n = 395) showed a very high degree of inter-rater agreement among the four centers despite differences in cytometers and software usage (intraclass correlation coefficient [ICC] 0.979 based on n = 800 single values). Lower concordance was reached with amounts of MRD below 0.1%. Comparing data from sample exchange experiments (n = 42 samples; ICC 0.98) and from independent patient cohorts from the four centers (regarding positive samples per time-point of follow-up as well as risk estimates) concordance was also good. Conclusion: MRD-evaluation by FCM in ALL can be standardized for reliable multicentric assessment in large trials. (C) 2008 Clinical Cytometry Society
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available